Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Central Neuropathic Pain in MS
NCT00755807Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of duloxetine in central neuropathic pain (CNP), sponsored by Eli Lilly and Company. Started Oct 2008; status: completed.
02
Drugs
duloxetine
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NCT00755807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755807.